Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.

Ko, Kwonmok; Knight, Gemma; Rucker, James J; Cleare, Anthony J

Ko, Kwonmok; Knight, Gemma; Rucker, James J; Cleare, Anthony J.

Afiliação

Ko K; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Knight G; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Rucker JJ; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Cleare AJ; National Institute for Health Research Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, King's College London, London, United Kingdom.

Front Psychiatry ; 13: 917199, 2022.

Article em En | MEDLINE | ID: mdl-35923458

Palavras-chave

ayahuasca; cancer-related distress; depressive disorders; ketamine; mystical experience; psilocybin; psychedelic therapy; substance use disorder (SUD)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google